Related Experiment Video
Updated: Jul 18, 2026
05:06
Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy
Published on: July 14, 2023
Diabetic neuropathy differs in type 1 and type 2 diabetes
Anders A F Sima1, Hideki Kamiya
1Department of Pathology, Wayne State University, 540 E. Canfield Ave. Detroit, MI 48201, USA. asima@med.wayne.edu
Annals of the New York Academy of Sciences
|December 8, 2006
Summary
Type 1 and type 2 diabetic polyneuropathy (DPN) show distinct early metabolic changes. Type 1 DPN progresses to more severe nerve damage due to unique structural and molecular differences.
Area of Science:
- Neurology
- Metabolic Disorders
- Diabetes Research
Background:
- Diabetic polyneuropathy (DPN) is a common complication of diabetes mellitus.
- Early metabolic abnormalities differ between type 1 and type 2 DPN.
- These differences influence initial functional deficits and disease progression.
Purpose of the Study:
- To elucidate the distinct early metabolic abnormalities in type 1 and type 2 DPN.
- To compare the progression of functional defects and structural changes in both types of DPN.
- To identify underlying molecular mechanisms driving differential DPN severity.
Main Methods:
- Comparative analysis of early metabolic profiles in type 1 and type 2 diabetes patients with DPN.
- Assessment of functional nerve deficits and structural nerve damage.
- Investigation of molecular pathways including insulin signaling, neurotrophic factors, and protein modifications.
Main Results:
- Type 2 DPN exhibits milder initial functional defects despite similar hyperglycemia due to distinct early metabolic phases.
- Type 1 DPN is characterized by more severe late-stage structural damage, including axonal atrophy and paranodal changes.
- Differences in insulin action and signal transduction in type 1 diabetes affect neurotrophic factor expression and downstream pathways.
Conclusions:
- Early metabolic differences significantly impact the initial presentation and progression of DPN in type 1 versus type 2 diabetes.
- Type 1 DPN involves unique structural and molecular pathologies leading to more severe nerve fiber loss.
- Understanding these mechanistic disparities is crucial for developing targeted therapeutic strategies for DPN.
Related Concept Videos
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...